Viewing Study NCT02597868


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2026-01-07 @ 3:52 PM
Study NCT ID: NCT02597868
Status: UNKNOWN
Last Update Posted: 2016-03-29
First Post: 2014-03-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module